Literature DB >> 34137640

Correction for Ackley et al., "A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort".

Tyler W Ackley1, Dayna McManus1, Jeffrey E Topal1,2, Brian Cicali3, Sunish Shah1,4.   

Abstract

Entities:  

Year:  2021        PMID： 34137640     DOI： 10.1128/AAC.00943-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.

Authors:  Rituvanthikaa Seethapathy; Sophia Zhao; Joshua D Long; Ian A Strohbehn; Meghan E Sise
Journal:  Kidney360       Date:  2021-12-03

Review 2.  The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections.

Authors:  Mark R Hickman; David L Saunders; Catherine A Bigger; Christopher D Kane; Patrick L Iversen
Journal:  PLoS Negl Trop Dis       Date:  2022-03-08

3.  Remdesivir use in COVID-19 patients with end-stage kidney disease on intermittent hemodialysis: An absolute contraindication?

Authors:  Issa Haddad; Priyal Agarwal; Mohamed Hassanein
Journal:  Ther Apher Dial       Date:  2022-03-16       Impact factor: 2.195
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.